BridgeMD
New treatment option for Opioid Use Disorder
Official title Expanding Medication-Assisted Therapies in Central Asia
ClinicalTrials.gov ID: NCT05579470
What this study is testing
- What it's testing
- Central Asia (CA) represents the most rapidly growing HIV epidemic region worldwide, concentrated in people who inject drugs (PWID) and their sexual partners, and scaling up opioid agonist therapies (OAT) in this region is the most cost-effective strategy to prevent new HIV infections, and more effective when combined with antiretroviral therapy (ART). The investigators propose to use the Network for the Improvement of Addiction Treatment (NIATx) implementation strategy to scale-up OAT in three diverse Central Asian countries (Kazakhstan, Kyrgyzstan, Tajikistan) and guided by the Exploration-Planning-Implementation-Sustainment (EPIS) framework.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- i. Aim 1: The for Aim 1 Consists of:
- Quantitative surveys for PWID
- 18 years or older
- Meeting DSM-V criteria for opioid dependence
- Be either treatment naïve and seeking OAT or be on OAT for \< 90 days
You likely can't join if
- Not willing to provide consent
See the full eligibility criteria
- i. Aim 1: The for Aim 1 Consists of:
- Quantitative surveys for PWID
- 18 years or older
- Meeting DSM-V criteria for opioid dependence
- Be either treatment naïve and seeking OAT or be on OAT for \< 90 days
- Organizational Assessments for OAT Delivery Staff
- 18 years or older
- Currently working as an OAT delivery professional at an OAT delivery site
- Focus Groups (PWID on OAT)
- 18 years or older
- Meeting DSM-V criteria for opioid dependence
- Be either treatment naïve and seeking OAT or be on OAT for \< 90 days
- Focus Groups (PWID not on OAT)
- 18 years or older
- Meeting Diagnostic and Statistical Manual of Mental Disorders(DSM)-V criteria for opioid dependence
- Be OAT naïve (defined as never having been on OAT or having not received treatment for \> 1 year)
- Focus Groups (OAT delivery staff)
- 18 years or older
- Currently working as an OAT delivery professional at an OAT delivery site ii. Aim 2: The for Aim 2 consists of:
- 18 years or older
- Currently assigned as a Chief Narcologist for an Oblast iii. Aim 3: The for Aim 3 consists of:
- 18 years or older
- Authorized as a professional to work at an OAT delivery site
- Not willing to provide consent
The study team makes the final eligibility decision.
Where it's taking place
- New Haven, Connecticut, United States
- Almaty, Kazakhstan
- Bishkek, Kyrgyzstan
- Dushanbe, Tajikistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New Haven, Connecticut, United States; Almaty, Kazakhstan; Bishkek, Kyrgyzstan; Dushanbe, Tajikistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.